Novartis today announced top-line results from the Phase III GCAptAIN study evaluating Cosentyx® (secukinumab) in adults with newly diagnosed or relapsing giant cell arteritis (GCA).

Vamos Racquets will open in East Hanover with padel, pickleball, fitness, coworking and more at the former Novartis campus ...